AUC-Guided Vancomycin in Severe Renal Impairment: Underpowered but Directionally Favorable
This small single-center retrospective study offers the first look at model-based area under the curve (AUC) vancomycin dosing in patients with an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m2, and its pharmacokinetic data on early exposure are more informative than its null clinical comparison.
📅 Journal publication: 2026·Last updated: Nov 3, 2026
Can AUC-guided vancomycin dosing reduce kidney risk in renal impairment?
Vancomycin dosing using area under the curve (AUC) guidance may reduce acute kidney injury (AKI) risk in patients with impaired renal function. AKI occurred in 22.7% of trough-guided vs. 10.0% of AUC-guided patients, with no significant difference (p = 0.29). No significant difference was found between dosing methods, but AUC-based dosing might be safer for severely impaired renal function. AUC-guided vancomycin dosing may lessen AKI risk in severe renal impairment.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Fujita K, Yamamoto K, Itohara K, Ogihara T, Sakaue T, Uda A, Morioka A, Yamashita K, Omura T, Yano I
Citation:Fujita K, Yamamoto K, Itohara K, et al. Incidence of Acute Kidney Injury in the Model-Based AUC-Guided Dosing of Vancomycin Compared with Conventional Trough-Guided Dosing in Patients with Severely Impaired Renal Function. Biological & pharmaceutical bulletin. 2026;49(10):1709-1717. doi:10.1248/bpb.b26-00361